跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
R-16
首页
药物
R-16
R-16
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
申请人: BRISTOL MYERS SQUIBB CO
优先权: 2002
US
2 件公开
T-type calcium channel blockers
申请人: NISSAN CHEMICAL IND LTD
优先权: 2004
CN
PROCESS FOR THE PREPARATION OF A CHIRAL PROSTAGLANDIN ENOL INTERMEDIATE AND INTERMEDIATE COMPOUNDS USEFUL IN THE PROCESS
申请人: EUROAPI HUNGARY LLC
优先权: 2019
CN
EP
US
4 件公开
BENZODITHIOPHENE BASED COPOLYMER CONTAINING THIENO [3,4-B]THIOPHENE UNITS AND PREPARING METHOD AND APPLICATIONS THEREOF
申请人: OCEAN S KING LIGHTING SCIENCE&TECHNOLOGY CO LTD
优先权: 2012
CN
EP
2 件公开
BENZODITHIOPHENE BASED COPOLYMER CONTAINING ISOINDOLINE-1,3-DIKETONE UNITS AND PREPARING METHOD AND APPLICATIONS THEREOF
申请人: OCEAN S KING LIGHTING SCIENCE&TECHNOLOGY CO LTD
优先权: 2012
CN
EP
2 件公开
Non-Steroidal Compounds Useful as Glucocorticoid Receptor Modulators
申请人: ORGANON NV
优先权: 2005
US
Anti-inflammatory indole derivatives
申请人: ASTRAZENECA AB
优先权: 1999
US
2 件公开
CARBAMATE COMPOUND
申请人: MITSUI CHEMICALS INC
优先权: 2023
CN
EP
US
WO
4 件公开
药物
反馈